Mometavet®

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 200536
  • Animal drug product ID 2902

What the source publishes

Holder
Dechra Veterinary Products LLC
Active ingredients
Clotrimazole Gentamicin Sulfate Mometasone furoate
Form
Suspension
Routes
Otic
Supply regime
RX

Names this record is found by

Complete source data
us:fda:animaldrugs:2104:2902
{
  "form": "Suspension",
  "name": "Mometavet®",
  "holder": "Dechra Veterinary Products LLC",
  "routes": [
    "Otic"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "RX",
  "nativeProduct": {
    "routes": [
      "Otic"
    ],
    "species": {
      "Dogs:43": "Dog, No Use Class Stated Or Implied"
    },
    "sortOrder": 0,
    "withdrawals": [],
    "doseFormName": "Suspension",
    "applicationId": null,
    "specifications": "Each gram contains gentamicin sulfate, USP equivalent to 3 mg gentamicin base; mometasone furoate anhydrous, USP equivalent to 1 mg mometasone; and 10 mg clotrimazole, USP.",
    "proprietaryName": "Mometavet®",
    "proprietaryNameId": 2902,
    "statusDescription": "RX"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2026-05-14",
    "sponsorName": "Dechra Veterinary Products LLC",
    "applicationId": 2104,
    "applicationType": "A",
    "proprietaryName": "Mometavet®\n",
    "applicationNumber": 200536,
    "activeIngredientName": "Clotrimazole\nGentamicin Sulfate\nMometasone furoate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "43",
      "label": "Dogs",
      "native": {
        "key": "Dogs:43",
        "population": "Dog, No Use Class Stated Or Implied"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Dog, No Use Class Stated Or Implied",
      "canonicalId": "dog",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2026-05-14",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 2104,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Clotrimazole\nGentamicin Sulfate\nMometasone furoate\n",
  "nativeApplicationType": "A",
  "applicationIngredients": [
    {
      "activeIngredientName": "Mometasone furoate",
      "activeIngredientTolerance": null
    },
    {
      "activeIngredientName": "Gentamicin Sulfate",
      "activeIngredientTolerance": "<p>A tolerance of 0.1 part per million is established for negligible residues of gentamicin sulfate in the uncooked edible tissues of chickens and turkeys. Tolerances are established for total residues of gentamicin in edible tissues of swine as follows: 0.1 part per million in muscle, 0.3 part per million in liver, and 0.4 part per million in fat and kidney. A tolerance of 0.1 part per million is established for negligible residues of gentamicin sulfate in the uncooked edible tissues of chickens and turkeys. Tolerances are established for total residues of gentamicin in edible tissues of swine as follows: 0.1 part per million in muscle, 0.3 part per million in liver, and 0.4 part per million in fat and kidney.</p>"
    },
    {
      "activeIngredientName": "Clotrimazole",
      "activeIngredientTolerance": null
    }
  ],
  "nativeApplicationNumber": 200536,
  "nativeProprietaryNameId": 2902,
  "restrictionObservations": [
    {
      "indicationText": "For the treatment of otitis externa in dogs caused by susceptible strains of yeast (<em>Malassezia pachydermatis</em>) and bacteria (<em>Pseudomonas</em> spp. [including <em>P. aeruginosa</em>], coagulase- positive staphylococci, <em>Enterococcus faecalis</em>, <em>Proteus mirabilis</em>, and beta-hemolytic streptococci).",
      "limitationText": "Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
      "populationText": "Dogs"
    }
  ],
  "withdrawalPeriodsStatus": "not-reported",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:2104:2902"